Related references
Note: Only part of the references are listed.Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast Cancer
Suzanne E. Wardell et al.
CLINICAL CANCER RESEARCH (2015)
Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts
Andiliy Lai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
New Global Survey Shows an Increasing Cancer Burden
David Carter
AMERICAN JOURNAL OF NURSING (2014)
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
Rinath Jeselsohn et al.
CLINICAL CANCER RESEARCH (2014)
From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs)
Suzanne E. Wardell et al.
STEROIDS (2014)
Bazedoxifene Exhibits Antiestrogenic Activity in Animal Models of Tamoxifen-Resistant Breast Cancer: Implications for Treatment of Advanced Disease
Suzanne E. Wardell et al.
CLINICAL CANCER RESEARCH (2013)
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy et al.
NATURE GENETICS (2013)
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R. Robinson et al.
NATURE GENETICS (2013)
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Erik R. Nelson et al.
SCIENCE (2013)
Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden
G. Frisk et al.
BRITISH JOURNAL OF CANCER (2012)
Research Resource: Transcriptional Profiling in a Cellular Model of Breast Cancer Reveals Functional and Mechanistic Differences Between Clinically Relevant SERM and Between SERM/Estrogen Complexes
Suzanne E. Wardell et al.
MOLECULAR ENDOCRINOLOGY (2012)
An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis
Barry S. Komm et al.
MATURITAS (2012)
Treatment of Breast Cancer Brain Metastases
Rachel A. Freedman et al.
CURRENT BREAST CANCER REPORTS (2012)
Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain
Renata Duchnowska et al.
BREAST CANCER RESEARCH (2012)
The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy
Suzanne E. Wardell et al.
BIOCHEMICAL PHARMACOLOGY (2011)
The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor α and Cyclin D1
Joan S. Lewis-Wambi et al.
MOLECULAR PHARMACOLOGY (2011)
Double-blind, Randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: Results from EFECT
Stephen Chia et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators
Bryan M. Wittmann et al.
CANCER RESEARCH (2007)
Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
L. Perey et al.
ANNALS OF ONCOLOGY (2007)
Letrozole for brain and scalp metastases from breast cancer - a case report
R. Madhup et al.
BREAST (2006)
Bazedoxifene acetate: A selective estrogen receptor modulator with improved selectivity
BS Komm et al.
ENDOCRINOLOGY (2005)
Design, synthesis, and preclinical characterization of novel, highly selective indole estrogens
CP Miller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Molecular mechanism of action at estrogen receptor α of a new clinically relevant antiestrogen (GW7604) related to tamoxifen
DJ Bentrem et al.
ENDOCRINOLOGY (2001)
The endometrium in breast cancer patients on tamoxifen
G Dallenbach-Hellweg et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2000)
Share Paper
